SMARAGD: The prospective national clinical research platform to study characteristics, treatment and outcomes of patients with ovarian, fallopian tube, primary peritoneal and endometrial cancer in Germany.

11. November 2022

Decker T, Wöckel A, Juhasz-Böss I, Zaiss M, Nusch A, Gratzke K, u. a. 2022.

Oncol Res Treat. 2022;45(suppl 2)(V273):72.